Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2015

View Archived Issues

DiamiR receives funding to evaluate microRNA biomarkers for Alzheimer's disease

Sirtex reports preliminary data from the SIRFLOX study

Targazyme and M.D. Anderson Cancer Center to conduct study of TZ-101-treated T Cells

AstraZeneca reports phase III topline results for PT-003

FDA orphan drug designations for two IPF drugs

Universitaet zu Koeln divulges anti-CD30 CAR T cells

Non-toxic mitochondrial protonophore formulation shows potential for T2D and NAFLD/NASH

ALN-TTRSC has clinical activity in TTR cardiac amyloidosis patients

Full results presented from phase III ANNEXA-R study of andexanet alfa

BR-297: a neuroprotective allopregnanolone analogue

Targeting amyloid binding alcohol dehydrogenase with frentizole derivatives

Ignyta acquires four oncology R&D assets from Teva Pharmaceutical

Yisheng Biopharma confirms new vaccine for rabies infection will enter human trials

Scioderm begins phase III trial of Zorblisa in patients with epidermolysis bullosa

Janssen acquires XO1

Can-Fite completes development of biomarker blood test for company's drugs

Heron Therapeutics reports data from phase I study of HTX-011

Amicus Therapeutics reports on meetings with EMA and FDA over migalastat

FDA awards orphan drug designation to Selten's SPI-026 for PAH

Actelion presents new antimalarials

University of Utah describes KDM1A inhibitors

Piramal develops FFAR1 agonists

Purdue Pharma presents new sodium Nav1.7 channel blockers

Evotec and Sanofi establish major strategic alliance

Anthera receives Cystic Fibrosis Foundation Therapeutics award to develop Sollpura

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...